%0 Journal Article
%@ 1438-8871
%I JMIR Publications
%V 27
%N 
%P e63110
%T Evidence on Digital HIV Self-Testing From Accuracy to Impact: Updated Systematic Review
%A Beecroft,Ashlyn
%A Vaikla,Olivia
%A Engel,Nora
%A Duchaine,Thomas
%A Liang,Chen
%A Pant Pai,Nitika
%+ Research Institute of the McGill University Health Centre, 5252 boul de Maisonneuve W., Montreal, QC, H4A 3S5, Canada, 1 514 934 1934 ext 44729, nitika.pai@mcgill.ca
%K digital HIV self-testing
%K impact
%K linkage
%K outcomes
%K HIV
%K HIV infection
%K HIV self-testing
%K self-testing
%K digital innovation
%K systematic review
%K accuracy
%K patient-centered
%K middle- to high-income countries
%K digital health
%K mHealth
%K health education
%K sexually transmitted diseases
%K sexual behavior
%D 2025
%7 4.3.2025
%9 Review
%J J Med Internet Res
%G English
%X Background: HIV self-testing has gained momentum following the approval of self-testing methods and novel technological advancements. Digital HIV self-testing involves completing an oral or blood-based HIV self-test with support from a digital innovation. Objective: We conducted a systematic review on the existing data analyzing digital HIV self-testing accuracy while updating research on digital HIV self-test acceptability, preference, feasibility, and impact. Methods: We searched Embase and PubMed for records on HIV self-testing with digital support. Included studies significantly incorporated a form of digital innovation throughout the HIV self-test process and reported quantitative data. For accuracy measures, the search spanned January 1, 2013, to October 15, 2024; for patient-centered and impact outcomes, we updated existing literature (June 16, 2021, to October 15, 2024) reported in a previous systematic review. Studies’ quality was assessed using the QUADAS 2 Tool, Newcastle-Ottawa Scale, and Cochrane Risk of Bias Tool 2. Results: Fifty-five studies (samples ranging 120-21,035, median 1267 participants) were summarized from 19 middle- to high-income countries. Seven studies reported on the accuracy of HIV self-testing with innovations from >5000 participants. Diagnostic performance metrics, including point estimates of specificity, sensitivity, positive predictive value, and negative predictive value were measured (n=3), and ranged from: 96.8% to 99.9%, 92.9% to 100.0%, 76.5% to 99.2%, and 99.2% to 100.0%, respectively. The percentage of invalid test results for oral and blood-based self-tests ranged from 0.2% to 12.7% (n=4). Fifty-one studies reported data on metrics beyond accuracy, including acceptability, preference, feasibility, and impact outcomes from >30,000 participants. Majority (38/51, 74.5%) were observational studies, while 25.5% (13/51) reported data from randomized controlled trials. Acceptability and preference outcomes varied from 64.5% to 99.0% (14/51) and 4.6% to 99.3% (8/51), respectively. Feasibility outcomes included test uptake (30.9% to 98.2%; 28/51), response rate (26.0% to 94.8%; 7/51), and visits to web-based providers (43.0% to 70.7%; n=4). Impact outcomes assessed new infections (0.0% to 25.8%; 31/51), first-time testers (2.0% to 53.0%; 26/51), result return proportions (22.1% to 100.0%; 24/51), linkage to care as both connections to confirmatory testing and counseling (53.0% to 100.0%; 16/51), and referrals for treatment initiation (44.4% to 98.1%; 8/51). The quality of studies varied, though they generally demonstrated low risk of bias. Conclusions: Digital innovations improved the accuracy of HIV self-test results, and were well-accepted and preferred by participants. Operationally, they were found to be feasible and reported impacting the HIV self-testing process. These findings are in favor of the use of digital HIV self-test innovations as a promising support tool and suggest that digital HIV self-tests’ service delivery models hold promise in not only facilitating HIV testing but also impacting operational outcomes that are crucial to reaching Joint United Nations Program on HIV/AIDS targets in middle- to high-income countries. Trial Registration: PROSPERO CRD42020205025; https://www.crd.york.ac.uk/prospero/CRD42020205025 
%M 40053740
%R 10.2196/63110
%U https://www.jmir.org/2025/1/e63110
%U https://doi.org/10.2196/63110
%U http://www.ncbi.nlm.nih.gov/pubmed/40053740
<!DOCTYPE html PUBLIC '-//W3C//DTD XHTML 1.0 Transitional//EN' 'http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd'>
<html xmlns='http://www.w3.org/1999/xhtml'>
<head>
<title>pFad - Phonifier reborn</title>
<meta http-equiv='Content-Type' content='text/html; charset=utf-8' />
</head>
<body>
<h1>Pfad - The Proxy pFad of &#169; 2024 Garber Painting. All rights reserved.</h1>


<!-- Disclaimer -->
<p>Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.</p>
<br>
<p>Alternative Proxies:</p><p><a href="http://clevelandohioweatherforecast.com/php-proxy/index.php?q=https://www.jmir.org/article/export/end/jmir_v27i1e63110" target="_blank">Alternative Proxy</a></p><p><a href="http://clevelandohioweatherforecast.com/pFad/index.php?u=https://www.jmir.org/article/export/end/jmir_v27i1e63110" target="_blank">pFad Proxy</a></p><p><a href="http://clevelandohioweatherforecast.com/pFad/v3index.php?u=https://www.jmir.org/article/export/end/jmir_v27i1e63110" target="_blank">pFad v3 Proxy</a></p><p><a href="http://clevelandohioweatherforecast.com/pFad/v4index.php?u=https://www.jmir.org/article/export/end/jmir_v27i1e63110" target="_blank">pFad v4 Proxy</a></p></body>
</html>